Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

GREY:AKLPF - Post Discussion

Akela Pharma Inc. > Insider
View:
Post by Consultor1 on Apr 07, 2011 8:13am

Insider

Someone has been reading our boards, not much but something.....



Akela Pharma Inc. (AKL)

As of April 6th, 2011
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Apr 06/11 Apr 06/11 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 500
.167 USD
Apr 04/11 Apr 04/11 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 500
.166 USD
Apr 04/11 Mar 27/11 Ingalls & Snyder, LLC Direct Ownership Warrants 55 - Expiration of warrants -1,780,000  
Mar 25/11 Mar 25/11 Boone, Horace Shepard Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report    
Jan 12/11 Dec 14/10 Rieder, Robert Direct Ownership Common Shares 10 - Acquisition in the public market 50,000
.130
Dec 29/10 Dec 23/10 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 500
.164 USD
Dec 22/10 Dec 22/10 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 1,500
.158 USD
Dec 20/10 Dec 20/10 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 500
.152 USD
Dec 20/10 Dec 20/10 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 500
.147 USD
Dec 20/10 Dec 20/10 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market 1,000
.153 USD
- Amended Filing

Consultor1
GLTA
Comment by Consultor1 on Apr 16, 2011 11:28am
Now that insider's continue to buy in the public market tells me that we should start hearing about future plans. However support still not that strong, it could as easily drop back to .14.Consultor1GLTA Apr 14/11 Apr 14/11 Emmelot, Rudy Direct Ownership Common Shares 10 - Acquisition in the public market  ...more  
Comment by Biostocks01 on Apr 16, 2011 5:08pm
Hi Consultor1,I also believe that something should happen soon. Insiders buy the stock and the volumes are more important on the market specially from TD.Believe mee someone is loading the truck.That could be interesting to have a discussion with Mckee...Bio
Comment by Consultor1 on Apr 17, 2011 9:23am
As soon as Gregory M. McKee, President & CEO of AKL start's putting out some up dates SP could easily move up to the .30-.50. Gregory can't keep saying it's the economy, or the markets, believe it was all the mergers they did in the pass.Grumpy this morningConsultor1GLTA
Comment by Consultor1 on Apr 22, 2011 9:13am
Insiders continue to buy and last half hour of the day Anon was in and moved it up to .21. Believe we may see .30 plus range in the coming weeks. Next quarter should be out middle of May, and if it continues it's strenght the SP should take a big bounce up wards.Consultor1GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities